Device Trial Radar · NCT07464353
xDot Access Management System Early Feasibility Study
Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Jun 16, 2026
Primary completion
Aug 2026
Study completion Aug 2026
Sponsor
- Lead sponsor
- xDot Medical, IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Mar 11, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to demonstrate safety and investigate effectiveness of the xDot Access Management System (AMS) for closure of large bore femoral-arterial and femoral-venous access sites.
Conditions
- Vascular Closure Devices
Interventions
xDot Access Management System (AMS)Device
The xDot AMS is designed to deliver the xDot Implant Unit in the anterior wall of the target vessel to close the puncture site.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from major complications of the target access siteTime frame: 30 days post-procedure
- Time to hemostasis (TTH)Time frame: During procedure
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Advocate Good Samaritan Hospital
Downers Grove, Illinois · Recruiting
CentraCare Heart and Vascular Center
Saint Cloud, Minnesota · Recruiting
Oklahoma Heart Institute
Tulsa, Oklahoma · Recruiting
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.